Oncology
On GDF-15 neutralisation and cachexia, with CatalYm
As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.
Digital
Sponsored
Why AI transformation is really about people
Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.
R&D
Boosting biotech in Basel – with Valentina Francia
pharmaphorum speaks with Valentina Francia from Basel Area Business and Innovation about why many life sciences startups are finding success in Basel.
R&D
Sponsored
Beyond recruitment: Creating patient engagement that lasts
In the final episode of our patient- and site-centric solutions interview series, Zoltan Varga discusses the importance of PRE.
R&D
Taking the microbiome seriously, with Sam Possemiers
pharmaphorum catches up with MRM Health founder and CEO Sam Possemiers at LSX 2026.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
